Clinical efficacy and safety analysis of aumolertinib in real-world treatment of EGFR-mutated advanced non-small-cell lung cancer

• Principais autores: Xiaojuan Zhang (Autor), Mina Zhang (Autor), Xinyang Du (Autor), Guowei Zhang (Autor), Yuanyuan Niu (Autor), Chunhua Wei (Autor), Lanwei Guo (Autor), Chao Shi (Autor), Hangfan Liu (Autor), Huijuan Wang (Autor)
• Formato: Livro
• Publicado em: Frontiers Media S.A., 2024-04-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Background: This study aims to determine the efficacy and safety profile of aumolertinib in the real-word treatment setting for advanced non-small-cell lung cancer (NSCLC) patients harboring epidermal growth factor receptor (EGFR) mutations.Methods: We retrospectively analyzed the clinical data of 1...